Drugs / PF-05175157
Trials 13
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 19 trials | ||||||
| Phase 1 | NCT01819922 | Apr → Oct 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01807377 | Apr → Aug 2013 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01821079 | Mar → Apr 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01757756 | Oct → Nov 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01537497 | Mar → May 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01469468 | Nov → Dec 2011 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01396161 | Jul 2011 → Feb 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01433380 | Jul 2011 → May 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01274663 | Nov 2010 → May 2011 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT02100527 | Apr → Oct 2014 | acne | Pfizer | Withdrawn | No outcome recorded |
| Phase 2 | NCT02053116 | Mar → Apr 2014 | type 2 diabetes mellitus | Pfizer | Terminated | No outcome recorded |
| Phase 2 | NCT02053103 | Mar → Apr 2014 | type 2 diabetes mellitus | Pfizer | Terminated | No outcome recorded |
| Phase 2 | NCT01792635 | Dec 2012 → May 2014 | type 2 diabetes mellitus | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-05175157 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02053116 ↗ |
| Modality | Small molecule | — CHEMBL3359265 ↗ |
| Route | Oral | “single oral doses of PF-05175157” NCT01274663 ↗ |